Navigation Links
Emerging (disease) markets
Date:8/15/2007

s, a terrible loss of food and income for families dependent on those animals.

Some of these impacts could be greatly reduced by directing attention to wildlife markets and trade where many pathogenic problems originate. Preventing the spread of pathogens among animal species will require either banning trade or extending the current regulatory frameworks used in the trade in domestic animals to the wildlife trade, which largely lacks regulations and monitoring in many countries. Control strategies at these trade hubs would include:

  • Strengthening and enforcing of disease-control and trade regulations
  • Developing and implementing quarantine procedures
  • Shifting the costs of controlling outbreaks to the animal suppliers and vendors
  • Ending trade that is unsustainable.

Preventing the spread of the next potential pandemic could depend on closing the valves through which pathogens currently flow, said Martin Gilbert, a WCS veterinarian currently studying diseases in wildlife markets in Asia. There is a sound basis for the tight restrictions on trade of livestock and sadly, those concepts have not been recognized for wildlife.


'/>"/>
Contact: John Delaney
jdelaney@wcs.org
718-220-3275
Wildlife Conservation Society
Source:Eurekalert

Page: 1 2

Related biology news :

1. Ecological destruction fuels emerging diseases
2. U of M researcher examines newly emerging deadly disease
3. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
4. Emerging staph strains found to be increasingly deadly and deceptive
5. Ticks, flukes, and genomics: Emerging pathogens revealed
6. Whitefly spreads emerging plant viruses
7. Post oak grasshoppers emerging
8. WCS says avian flu prevention should focus on farms, markets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... single bacterial gene into yeast, researchers fro...s achieved three improvements in bioethanol produc...ol, less acetate and elimination of the major by-p...shed in the scientific journal Applied and Enviro...ol is made by the yeast Saccharomyces cerevisiae f...
(Date:11/20/2009)... Research Center (ERC) has been awarded a grant fr...methods of recovering and reusing the heat that wo...pression process in a carbon capture system. The g...n capture and sequestration, or storage (CCS), and... emitted into the atmosphere by coal-fired power p...
(Date:11/19/2009)...ists are revealing the genetic instructions inside... maize, has one of the most complex sequences of D...ison genomicist David Schwartz, who was one of mor...Science . , "The maize genome is a true maze fu...oubled would-be sequencers for years," says Schwar...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 1Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 2Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 3Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 4Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 5Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 6Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 1Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 2Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 3Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 4Fresenius Medical Care N A Has Selected VitalRemedyMDs VitalProteinRx 28TM 29 As Its Bar of Choice for Protein Replacement in Dialysis Patients 5360 1Fresenius Medical Care N A Has Selected VitalRemedyMDs VitalProteinRx 28TM 29 As Its Bar of Choice for Protein Replacement in Dialysis Patients 5360 2
...HICAGO Research studies featured in the October 2...nclude: , Dietary Restraint and Gestational Wei...roves Folate Intake and Food-Related Behaviors in ..., Changes in Nutrient Intake and Dietary Quality a... Low-Fat Vegan Diet or a Conventional Diabetes Die...
...University of Illinois microbiology professor Will... way to mass-produce an antimalarial compound, pot...nsive. , Metcalf set out to understand how this...s made in nature by bacteria. He was interested in...e antibiotic properties. Recently, Metcalf and his...
...he global scientific community will gather in Mapu...l Assembly (GA) of the International Council for S...d in sub-Saharan Africa. , More than 250 leading ...r at this unique event to discuss and address how ... pressing challenges facing society, including: hu...
Other Biology News:News from the October 2008 Journal of the American Dietetic Association 2New way to make malaria medicine also first step in finding new antibiotics 2New way to make malaria medicine also first step in finding new antibiotics 3New way to make malaria medicine also first step in finding new antibiotics 4Global science community to gather in Mozambique 2
(Date:11/19/2009)...N, Nov. 19 Danish Prince Joachim i...ethanol plant in Kalundborg, Denmark, on Wednesday...first and largest 2nd generation ethanol demonstra... are used in the plant,s innovative process for co...nisco, was the first to market with commercial enz...
(Date:11/19/2009)..., Nov. 19 NeoStem, Inc. ...nt the following letter to its shareholders, discu...09, of China Biopharmaceuticals Holdings, Inc. (CH...d in the People,s Republic of China. The merger gi...yre Pharmaceutical Co. Ltd., CHBP,s primary operat...
(Date:11/19/2009)..., Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. ... a randomized Phase 2B study of AEG35156, a target...for multiple oncology indications. ,, The study... of the X-Linked Inhibitor of Apoptosis (XIAP) Ant...e Cytarabine and Idarubicin in AML Following Failu...
(Date:11/19/2009)...VIENNA, Austria, November 19 AFFiR...n one product candidate at an unexpectedly early,s... planned to enter into,Phase II clinical trial ear...ly follows the completion of two Phase I trials wi... its fast decision on the first interim,analysis o...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...SQUAN, NJ., March 31 BioSpace, the world,s leadin...eer fair company, will host,the Biotech Beach(TM) ...The,event will take place at the Hyatt Regency La ....com/cgi-bin/prnh/20080222/CLF013LOGO ), Life sc...a will attend,the biotech job fair to meet in pers...
...POLIS, Md., March 31 PharmAthene, Inc.,(Amex: PI...rmeasures against,biological and chemical threats,...ed December 31, 2007., David P. Wright, President...e continued to advance both our corporate and prod...f important milestones which included,obtaining ad...
...ON, Mass., March 31 Tryton Medical, Inc., the,lea...ve treatment of,bifurcation lesions announced toda...of financing. Two new investors, PTV Sciences and ...re Partners in the financing. Rick Anderson,from P...inted to the Tryton,Board of Directors., "Bifurca...
Other Biology Technology:Bioscience Career Fair in San Diego Expected to Draw Record Jobseeker Attendance 2PharmAthene Reports Year-End 2007 Financial Results 2PharmAthene Reports Year-End 2007 Financial Results 3PharmAthene Reports Year-End 2007 Financial Results 4PharmAthene Reports Year-End 2007 Financial Results 5PharmAthene Reports Year-End 2007 Financial Results 6PharmAthene Reports Year-End 2007 Financial Results 7PharmAthene Reports Year-End 2007 Financial Results 8PharmAthene Reports Year-End 2007 Financial Results 9Tryton Medical, Inc. Closes $14 Million Financing 2Tryton Medical, Inc. Closes $14 Million Financing 3
Taq DNA Polymerase from QIAGEN
BD BioCoat Poly-D-Lysine 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Laminin 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 35 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: